BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24083701)

  • 1. Screening of differentially expressed genes related to bladder cancer and functional analysis with DNA microarray.
    Huang YD; Shan W; Zeng L; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(8):4553-7. PubMed ID: 24083701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis and verification of the interaction network of differentially expressed genes in invasive bladder cancer].
    Shi R; Zhao Z; Gao Y; Wu QH; Song YB; Jiang L; Zheng WL; Ma WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1771-4. PubMed ID: 20813661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.
    Mares J; Szakacsova M; Soukup V; Duskova J; Horinek A; Babjuk M
    Neoplasma; 2013; 60(3):295-301. PubMed ID: 23452234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of key genes of unruptured intracranial aneurysms by using DNA microarray data analysis techniques.
    Chen L; Fan Y; Wan J
    Genet Mol Res; 2014 Jan; 13(1):758-67. PubMed ID: 24615040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of differentially expressed genes related to ischemic stroke and functional analysis with DNA microarray.
    Zhang ZL; Wu WC; Liu JQ; Yao YB; Pan MD; Yang CB; Wang JG; Huang XW; Lin JY
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1181-8. PubMed ID: 24817293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
    He TL; Zheng KL; Li G; Song B; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
    Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
    Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
    Sui W; Shi Z; Xue W; Ou M; Zhu Y; Chen J; Lin H; Liu F; Dai Y
    Oncol Rep; 2017 Mar; 37(3):1804-1814. PubMed ID: 28184940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers.
    Mengual L; Burset M; Ars E; Lozano JJ; Villavicencio H; Ribal MJ; Alcaraz A
    J Urol; 2009 Aug; 182(2):741-8. PubMed ID: 19539325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Bi D; Ning H; Liu S; Que X; Ding K
    Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and Bioinformatics Analyses Identify 7 Circular RNAs Involved in Regulation of Oncogenic Transformation and Cell Proliferation in Human Bladder Cancer.
    Cai D; Liu Z; Kong G
    Med Sci Monit; 2018 Mar; 24():1654-1661. PubMed ID: 29558461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Li W; Liu J; Zou D; Cai X; Wang J; Wang J; Zhu L; Zhao L; Ou R; Xu Y
    Oncol Rep; 2017 Mar; 37(3):1461-1468. PubMed ID: 28184944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.